{"address1": "Grenzacherstrasse 124", "city": "Basel", "zip": "4058", "country": "Switzerland", "phone": "41 61 688 11 11", "fax": "41 61 691 00 14", "website": "https://www.roche.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.", "fullTimeEmployees": 103605, "companyOfficers": [{"maxAge": 1, "name": "Dr. Severin  Schwan Ph.D.", "age": 56, "title": "Executive Chairman", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 7509307, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas  Schinecker", "age": 48, "title": "Chief Executive Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": 3869052, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Hippe", "age": 56, "title": "Chief Financial & Information Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 4106374, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bruno  Eschli", "title": "Head of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Claudia  Bockstiegel", "age": 59, "title": "General Counsel", "yearBorn": 1964, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pascale  Schmidt", "age": 50, "title": "Chief Compliance Officer", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Barbara  Schadler", "age": 61, "title": "Head of Group Communications", "yearBorn": 1962, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristina A. Wilbur", "age": 56, "title": "Chief People Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 2921524, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nicolas  Dunant", "title": "Head of Group Media Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Boris L. Zaitra", "age": 51, "title": "Head of Group Business Development and M&A", "yearBorn": 1972, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 230.95, "open": 229.0, "dayLow": 224.05, "dayHigh": 230.3, "regularMarketPreviousClose": 230.95, "regularMarketOpen": 229.0, "regularMarketDayLow": 224.05, "regularMarketDayHigh": 230.3, "dividendRate": 9.6, "dividendYield": 0.0416, "exDividendDate": 1710374400, "payoutRatio": 0.6639, "fiveYearAvgDividendYield": 3.05, "beta": 0.147, "trailingPE": 15.715783, "forwardPE": 10.701379, "volume": 2338691, "regularMarketVolume": 2338691, "averageVolume": 1319677, "averageVolume10days": 1922239, "averageDailyVolume10Day": 1922239, "bid": 225.0, "marketCap": 180713586688, "fiftyTwoWeekLow": 222.75, "fiftyTwoWeekHigh": 293.55, "priceToSalesTrailing12Months": 2.989917, "fiftyDayAverage": 236.548, "twoHundredDayAverage": 249.94424, "trailingAnnualDividendRate": 9.6, "trailingAnnualDividendYield": 0.04156744, "currency": "CHF", "enterpriseValue": 208410034176, "profitMargins": 0.19024, "floatShares": 727475302, "sharesOutstanding": 690550976, "heldPercentInstitutions": 0.39375, "impliedSharesOutstanding": 802993024, "bookValue": 36.771, "priceToBook": 6.120312, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "earningsQuarterlyGrowth": 0.121, "netIncomeToCommon": 11498000384, "trailingEps": 14.32, "forwardEps": 21.03, "pegRatio": 2.68, "lastSplitFactor": "100:1", "lastSplitDate": 988934400, "enterpriseToRevenue": 3.448, "enterpriseToEbitda": 9.963, "52WeekChange": -0.1060577, "SandP52WeekChange": 0.32311738, "lastDividendValue": 9.6, "lastDividendDate": 1710374400, "exchange": "EBS", "quoteType": "EQUITY", "symbol": "ROG.SW", "underlyingSymbol": "ROG.SW", "shortName": "ROCHE GS", "longName": "Roche Holding AG", "firstTradeDateEpochUtc": 796892400, "timeZoneFullName": "Europe/Zurich", "timeZoneShortName": "CET", "uuid": "1081a5a0-714d-39d3-a148-0631688df86e", "messageBoardId": "finmb_687140", "gmtOffSetMilliseconds": 3600000, "currentPrice": 225.05, "targetHighPrice": 429.0, "targetLowPrice": 300.0, "targetMeanPrice": 364.36, "targetMedianPrice": 371.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 22, "totalCash": 10510999552, "totalCashPerShare": 13.184, "ebitda": 20917999616, "totalDebt": 30850000896, "quickRatio": 0.942, "currentRatio": 1.347, "totalRevenue": 60441001984, "debtToEquity": 92.746, "revenuePerShare": 75.646, "returnOnAssets": 0.12442, "returnOnEquity": 0.37862998, "freeCashflow": 8604375040, "operatingCashflow": 16094999552, "earningsGrowth": 0.129, "revenueGrowth": -0.065, "grossMargins": 0.74195, "ebitdaMargins": 0.34609002, "operatingMargins": 0.23896, "financialCurrency": "CHF", "trailingPegRatio": 1.5657}